Newleos Therapeutics

Newleos Therapeutics is a clinical-stage biotechnology company co-founded by Longwood Fund and seasoned CNS drug-development leaders, headquartered in Boston, Massachusetts. Its pipeline, licensed from Roche, develops oral small-molecule therapeutics targeting GABAA-gamma1, V1a, TAAR1 and GABAA-alpha5 mechanisms, with first- or best-in-class potential for general anxiety, social anxiety, substance use disorders, and cognitive impairment. Newleos is a pharmaceutical R&D company with no public developer or API product surface; this profile captures its corporate web presence for the API Evangelist network.

Newleos Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Mental Health, and Neuroscience.

Newleos Therapeutics’ developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsMental HealthNeuroscienceClinical TrialsHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 12.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/newleos-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: newleos-therapeutics
name: Newleos Therapeutics
description: Newleos Therapeutics is a clinical-stage biotechnology company co-founded by Longwood Fund and seasoned CNS drug-development
  leaders, headquartered in Boston, Massachusetts. Its pipeline, licensed from Roche, develops oral small-molecule therapeutics
  targeting GABAA-gamma1, V1a, TAAR1 and GABAA-alpha5 mechanisms, with first- or best-in-class potential for general anxiety,
  social anxiety, substance use disorders, and cognitive impairment. Newleos is a pharmaceutical R&D company with no public
  developer or API product surface; this profile captures its corporate web presence for the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/newleos-therapeutics/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://newleos.com/wp-content/uploads/ico-newleos.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Mental Health
- Neuroscience
- Clinical Trials
- Healthcare
apis: []
common:
- type: Website
  url: https://newleos.com/
- type: Blog
  url: https://newleos.com/news/
- type: PrivacyPolicy
  url: https://newleos.com/privacy-policy/
- type: TermsOfService
  url: https://newleos.com/terms-of-use/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 0
  pass: local-v1